21
Nov 24
New AIFA guidelines on simplification and decentralization of clinical trials
The AIFA approved guidelines concerning simplification and decentralization of clinical trials of medicines, on the same day as those on observational studies.
21
Nov 24
Transparency in clinical trials: Revised transparency rules take effect
The major changes under the revised transparency rules for the Clinical Trials Regulation and its Clinical Trials Information System, issued by the EMA in October 2023, should lead to faster publication of key documents (including protocols) and should make the system easier to use.
21
Nov 24
The Dabus case: Artificial intelligence cannot be designated as the inventor in a patent
Artificial intelligence plays a fundamental role in the life sciences sector, offering the opportunity to facilitate various processes. However, such use also raises numerous ethical and legal questions that touch on responsibility, reliability, and the correct and legal use of data and information to train AI for new technical solutions.
20
Nov 24
AI and healthcare: A question of liability
Artificial intelligence (AI) systems of varying levels of sophistication are increasingly used in health care in conjunction with various medical services.
